Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.
Lee CG, Heckman-Stoddard B, Dabelea D, Gadde KM, Ehrmann D, Ford L, Prorok P, Boyko EJ, Pi-Sunyer X, Wallia A, Knowler WC, Crandall JP, Temprosa M; Diabetes Prevention Program Research Group; Diabetes Prevention Program Research Group:. Lee CG, et al. Among authors: temprosa m. Diabetes Care. 2021 Dec;44(12):2775-2782. doi: 10.2337/dc21-1046. Epub 2021 Oct 25. Diabetes Care. 2021. PMID: 34697033 Free PMC article. Clinical Trial.
The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.
Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S; Diabetes Prevention Program Research Group. Orchard TJ, et al. Among authors: temprosa m. Ann Intern Med. 2005 Apr 19;142(8):611-9. doi: 10.7326/0003-4819-142-8-200504190-00009. Ann Intern Med. 2005. PMID: 15838067 Free PMC article. Clinical Trial.
Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance.
Haffner S, Temprosa M, Crandall J, Fowler S, Goldberg R, Horton E, Marcovina S, Mather K, Orchard T, Ratner R, Barrett-Connor E; Diabetes Prevention Program Research Group. Haffner S, et al. Among authors: temprosa m. Diabetes. 2005 May;54(5):1566-72. doi: 10.2337/diabetes.54.5.1566. Diabetes. 2005. PMID: 15855347 Free PMC article. Clinical Trial.
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.
Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, Haffner SM, Andres R, Saudek C, Edelstein SL, Arakaki R, Murphy MB, Shamoon H; Diabetes Prevention Program Research Group. Kitabchi AE, et al. Among authors: temprosa m. Diabetes. 2005 Aug;54(8):2404-14. doi: 10.2337/diabetes.54.8.2404. Diabetes. 2005. PMID: 16046308 Free PMC article. Clinical Trial.
Evaluating the accuracy of an aneroid sphygmomanometer in a clinical trial setting.
Ma Y, Temprosa M, Fowler S, Prineas RJ, Montez MG, Brown-Friday J, Carrion-Petersen ML, Whittington T; Diabetes Prevention Program Research Group. Ma Y, et al. Among authors: temprosa m. Am J Hypertens. 2009 Mar;22(3):263-6. doi: 10.1038/ajh.2008.338. Epub 2008 Dec 4. Am J Hypertens. 2009. PMID: 19057514 Free PMC article.
Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group.
Goldberg RB, Temprosa M, Haffner S, Orchard TJ, Ratner RE, Fowler SE, Mather K, Marcovina S, Saudek C, Matulik MJ, Price D; Diabetes Prevention Program Research Group. Goldberg RB, et al. Among authors: temprosa m. Diabetes Care. 2009 Apr;32(4):726-32. doi: 10.2337/dc08-0494. Epub 2009 Jan 26. Diabetes Care. 2009. PMID: 19171717 Free PMC article. Clinical Trial.
86 results